Variant report
Variant | esv3384555 |
---|---|
Chromosome Location | chr2:185537407-185542705 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572020038 | chr2:185537810-185537811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376073758 | chr2:185537872-185537873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556777213 | chr2:185537893-185537894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs137936249 | chr2:185537989-185537990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185915049 | chr2:185538036-185538037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575823330 | chr2:185538063-185538064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543360361 | chr2:185538067-185538068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565012928 | chr2:185538075-185538076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7601869 | chr2:185538107-185538108 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs541031753 | chr2:185538118-185538119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559818007 | chr2:185538121-185538122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs72899952 | chr2:185538154-185538155 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs374856235 | chr2:185538193-185538194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191074902 | chr2:185538251-185538252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553598206 | chr2:185538300-185538301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142410468 | chr2:185538325-185538326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1480480 | chr2:185538399-185538400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552930175 | chr2:185538401-185538402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200106458 | chr2:185538431-185538432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148237725 | chr2:185538475-185538476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547033360 | chr2:185538501-185538502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565780057 | chr2:185538591-185538592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572147842 | chr2:185538612-185538613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77551852 | chr2:185538656-185538657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554241292 | chr2:185538699-185538700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs575860414 | chr2:185538708-185538709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536834567 | chr2:185538777-185538778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183267517 | chr2:185538800-185538801 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558828057 | chr2:185538860-185538861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs546774948 | chr2:185538884-185538885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541417469 | chr2:185538917-185538918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6728764 | chr2:185538930-185538931 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs575295276 | chr2:185539040-185539041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186878109 | chr2:185539063-185539064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560581114 | chr2:185539065-185539066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191537701 | chr2:185539068-185539069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563748066 | chr2:185539190-185539191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs531161561 | chr2:185539253-185539254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552468352 | chr2:185539256-185539257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564806420 | chr2:185539262-185539263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528741594 | chr2:185539345-185539346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547266104 | chr2:185539352-185539353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565384529 | chr2:185539385-185539386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368472837 | chr2:185539386-185539387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141371475 | chr2:185539401-185539402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs569378827 | chr2:185539423-185539424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536867754 | chr2:185539485-185539486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs10708796 | chr2:185539523-185539524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs375353913 | chr2:185539529-185539530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368736069 | chr2:185539530-185539531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Autism | 22543975 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:185537800-185538800 | Enhancers | Brain Germinal Matrix | brain |
2 | chr2:185538800-185544200 | Weak transcription | Brain Germinal Matrix | brain |